Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model.

The bleeding disorder of hemophilia A currently treated by replacement therapy of the missing coagulation factor, factor VIII, is frequently complicated by the development of neutralizing antibodies. The therapeutic potential of attenuated forms of the lipid-associated glycoprotein tissue factor, a...

Olles dieđut

Bibliográfalaš dieđut

Publikašuvnnas:	J Clin Invest
Váldodahkkit:	O'Brien, D P, Giles, A R, Tate, K M, Vehar, G A
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	American Society for Clinical Investigation 1988
Fáttát:	Research Article
Liŋkkat:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303495/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3134399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113571
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!